FDA Approves Less Expensive Insulin Glargine (FREE)

By Kristin J. Kelley Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS The FDA has approved an insulin glargine injection (marketed as Basaglar) for treating type 1 (adult and pediatric patients) and …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news